Association of Transmembrane Immunoglobulin and Mucin Domain rs10515746 Polymorphism With Severity and Mortality of COVID-19 in the Iranian Population
Immunoregulation · 18.07.2026 · 8 (1) · 0-0
DOI: 10.32598/immunoregulation.8.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunoregulation, online erschienen am 18.07.2026. Verfasst von Ensie sadat Mirsharif und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) is an inhibitory immune checkpoint regulating T cell immune responses. This study aimed to evaluate the association between the TIM-3 rs10515746 single-nucleotide polymorphism and the severity and mortality of coronavirus disease 2019 (COVID-19) among Iranians. Materials and Methods: Genomic DNA was extracted from peripheral blood nucleated cells of 828 COVID-19 patients and 166 healthy controls without COVID-19. The TIM-3 polymorphic site was analyzed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. To determine whether genetic variation was associated with hepatitis A virus cellular receptor 2 (HAVCR-2) messenger ribonucleic acid (mRNA) expression, total RNA was extracted from 175 COVID-19 patients and 65 healthy controls, and HAVCR-2 expression levels were quantified using reverse transcription-polymerase chain reaction (RT-PCR).
Results
The genotypic frequencies of TIM-3 574A>C (rs10515746) polymorphism were in accordance with the Hardy-Weinberg equilibrium in the healthy control subjects (P>0.05). No significant difference was observed in their distribution frequencies of rs10515746 between the genotypes and alleles among COVID-19 patients vs. controls, inpatients vs outpatients, intensive care unit (ICU) vs non-ICU admitted patients, and survivors vs. non-survivors under different genetic models. Also, no significant difference was observed in the mRNA expression of HAVCR-2 in COVID-19 patients with other genotypes.
Conclusion
COVID-19 infection was not associated with the TIM-3 574A>C (rs10515746) polymorphism among the Iranians.
Zitieren
APA
Mirsharif, E. S., Rostamian, A., Salehi, M., Askari, N., & Ghazanfari, T. (2026). Association of Transmembrane Immunoglobulin and Mucin Domain rs10515746 Polymorphism With Severity and Mortality of COVID-19 in the Iranian Population. Immunoregulation, 8(1), 0-0. https://doi.org/10.32598/immunoregulation.8.17
Vancouver
Mirsharif ES, Rostamian A, Salehi M, Askari N, Ghazanfari T. Association of Transmembrane Immunoglobulin and Mucin Domain rs10515746 Polymorphism With Severity and Mortality of COVID-19 in the Iranian Population. Immunoregulation. 2026;8(1):0-0. doi:10.32598/immunoregulation.8.17
BibTeX
@article{Mirsharif2026,
author = {Mirsharif, Ensie sadat and Rostamian, Abdolrahman and Salehi, Mohammadreza and Askari, Nayere and Ghazanfari, Tooba},
title = {Association of Transmembrane Immunoglobulin and Mucin Domain rs10515746 Polymorphism With Severity and Mortality of COVID-19 in the Iranian Population},
journal = {Immunoregulation},
year = {2026},
volume = {8},
number = {1},
pages = {0--0},
doi = {10.32598/immunoregulation.8.17}
}
EUVIMED